Publications

Minji Kim, Eunjin Hong.

Analysis of Real‐World Data Utilization in the Orphan Drug Approval Process: Focusing on New Drug Marketing Applications Submitted to the FDA

Clinical Pharmacology & Therapeutics (JCR Pharmacology & Pharmacy 6.9%)

https://doi.org/10.1002/cpt.70228  (Corresponding author)   

Seonyoung Byoun, Dong-Gyu Heo, Minsoo Lee, Ryunghwa Lee, Yuanyuan Li, Ju-Yeun Lee, Eunjin Hong‡, Wooin Lee‡.

Enhanced CYP2C19-mediated drug-drug interaction risk with escitalopram in geriatric populations

Frontiers in Pharmacology  (JCR Pharmacology & Pharmacy 14.3%)

https://doi.org/10.3389/fphar.2025.1711196  (‡: Co-corresponding author) 

Madeline  Sanders†,  Eunjin  Hong†,  Peter  Chung  et  al.  

Evaluation  of  the  drug  interaction  between  rifabutin  and elexacaftor/tezacaftor/ivacaftor (ETI)

Journal of Cystic Fibrosis  (JCR Respiratory System 10.6%)

https://doi.org/10.1016/j.jcf.2025.09.002  (†: Co-first author)

Yoo Jin Jang, Doh Kwan Kim, Shin-Won Lim, Eunjin Hong. 

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics:  Based  on  Physiologically-Based  Pharmacokinetic  Modeling  and  Clinical  Observation

Clinical  Pharmacology  & Therapeutics (JCR Pharmacology & Pharmacy 6.9%)

https://doi.org/10.1002/cpt.3537  (Corresponding author)   

Dong-Gyu Heo, Madeline Sanders, Vinicius Calado Nogueira de Moura, Charles L Daley, Paul M Beringer‡, Eunjin Hong‡.

Dose optimization of omadacycline for the treatment of nontuberculous mycobacterial pulmonary disease (NTM-PD) using a physiologically based pharmacokinetic modeling approach

Journal of Pharmaceutical Investigation (JCR Pharmacology & Pharmacy 9.7%)

https://doi.org/10.1007/s40005-025-00776-0  (‡: Co-corresponding author) 

Yunjoung Kim, Eunjin Hong‡, Hyekyung Park‡

Community pharmacists’ perceptions of dispensing long-term prescriptions exceeding 90 days–A survey of pharmacists from a single pharmacy chain

Korean Journal of Clinical Pharmacy (2025)  (‡: Co-corresponding author) 

Eunjin Hong, Mary F Hebert, Emily Fay et al. 

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

Clinical Pharmacology & Therapeutics (JCR Pharmacology & Pharmacy 6.9%)

https://doi.org/10.1002/cpt.3705 (First author)

Eunjin Hong, Sarah Parsons, Laura Sass et al. 

Preliminary evidence for sustained efficacy of CFTR modulator therapy with concomitant rifabutin administration

Journal of Cystic Fibrosis  (JCR Respiratory System 10.6%)

https://doi.org/10.1016/j.jcf.2023.11.015 (First author)

Eunjin Hong, Regina Li, Alan Shi et al. 

Safety of elexacaftor/tezacaftor/ivacaftor dose reductions: mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series

Pharmacotherapy (JCR Pharmacology & Pharmacy 15.6%) 

https://doi.org/10.1002/phar.2786 (First author)

Tian Xia, Xin Wu, Eunjin Hong et al. 

Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion

PLoS Pathogen (JCR PARASITOLOGY 5.6%) 

https://doi.org/10.1371/journal.ppat.1011232

Eunjin Hong, Eugeniu Carmanov, Alan Shi et al.

Application of physiologically-based pharmacokinetic modeling to predict drug- drug interactions between ivacaftor and tacrolimus in lung transplant patients 

Pharmaceutics (JCR Pharmacology & Pharmacy 12.9%) 

https://doi.org/10.3390/pharmaceutics15051438 (First author)

Eunjin Hong, Alan Shi, Paul Beringer. 

Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications

Expert Opinion on Drug Metabolism & Toxicology (2023) 

https://doi.org/10.1080/17425255.2023.2220960 (First author)

Eunjin Hong, Lisa Almond, Peter Chung et al. 

Physiologically‐Based Pharmacokinetic‐Led Guidance for Patients with Cystic Fibrosis Taking Elexacaftor‐Tezacaftor‐Ivacaftor With Nirmatrelvir‐Ritonavir for the Treatment of COVID‐19

Clinical Pharmacology & Therapeutics (JCR Pharmacology & Pharmacy 6.9%)

https://doi.org/10.1002/cpt.2585 (First author)

Eunjin Hong, Lisa Almond, Peter Chung et al.

Physiologically-Based Pharmacokinetic (PBPK) modeling to guide management of drug interactions between elexacaftor-tezacaftor-ivacaftor and antibiotics for the treatment of non-tuberculosis mycobacteria (NTM)

Antimicrobial Agents and Chemotherapy (JCR Pharmacology & Pharmacy 18%)

https://doi.org/10.1128/aac.01104-2212 (First author)

Weiqiang Chen, Suan-Sin Foo, Eunjin Hong et al. 

Zika virus NS3 protease induces bone morphogenetic protein-dependent brain calcification in human fetuses

Nature Microbiology (JCR Microbiology 3.3%)

https://doi.org/10.1038/s41564-020-00850-3